Tom Frohlich is the founder of Chinook Therapeutics. Chinook Therapeutics has raised $65M in total funding. Latest round: Series A.
Tom Frohlich is the Chief Business Officer at Chinook Therapeutics, a company focused on discovering and developing precision medicines for kidney diseases. Before joining Chinook, Mr. Frohlich was vice president of business development at Arbutus. Chinook Therapeutics raised a $65 million Series A financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library